Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Rigel Pharmaceuticals, Inc.”

373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 373
Index total 30,257
Page 13 / 16

Quick answer

This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

373 results for “Rigel Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 7872000

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted
  2. US 7872096

    Methods for cyclizing synthetic polymers

    Rigel Pharmaceuticals, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted
  3. US 7868013

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted
  4. US 7863286

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted
  5. US 7858633

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted
  6. US 7851480

    Spiro 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  7. US 7834024

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  8. US 7825116

    N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines

    Rigel Pharmaceuticals, Inc. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  9. US 7820819

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  10. US 7812029

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  11. US 7803939

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted
  12. US 7776847

    Benzisothiazoles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted
  13. US 7754714

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  14. US 7723018

    Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade

    Rigel Pharmaceuticals, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  15. US 7713987

    Pyrimidine-2,4-diamines and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 11, 2010 · Expires May 6, 2030

    granted
  16. US 7714137

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted May 11, 2010 · Expires May 6, 2030

    granted
  17. US 7709482

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  18. US 7659280

    2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases

    Rigel Pharmaceuticals, Inc. · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  19. US 7655797

    Intermediates for making 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  20. US 7601713

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  21. US 7589200

    5-Fluoro-4N-phenyl-4-pyrimidineamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  22. US 7585883

    Substituted pyridines and their uses

    Rigel Pharmaceuticals, Inc. · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  23. US 7582648

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  24. US 7576053

    Methods and compositions for treating degenerative bone disorders

    Rigel Pharmaceuticals, Inc. · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted